Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

BlackThorn Therapeutics develops precision medicines that target dysfunctional brain circuits to treat central nervous system and neurobehavioral disorders. The company applies advances in…

BlackThorn Therapeutics develops precision medicines that target dysfunctional brain circuits to treat central nervous system and neurobehavioral disorders. The company applies advances in…
Founded: 2015
Headquarters: San Francisco, California, USA
Focus: Precision therapeutics for CNS and neurobehavioral disorders using computational neuroscience and AI
Clinical stage: Yes
Notable financing: Series B $76M (Jun 13, 2019); total reported funding ~$138M
Central nervous system (CNS) and neurobehavioral disorders; neuropsychiatry.
2015
Biotechnology
76,000,000 USD
Series B participation included GV (Google Ventures), Johnson & Johnson Innovation, Polaris Partners, ARCH Venture Partners and others.
~40,000,000 USD
Series A activity reported around 2016–2017.
“ARCH Venture Partners; GV (Google Ventures); Johnson & Johnson Innovation; Polaris Partners; The Scripps Research Institute; Biomatics Capital Partners; Vertex Ventures HC; Mercury”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week